“…A conotoxin precursor typically comprises 6-50 amino acid residues (aa) with an N-terminal hyper-conserved signal peptide region, a precursor region that may be present or absent, and a C-terminal hyper-variable mature toxin region (Livett et al, 2004;Kaas et al, 2010;Jin et al, 2019b). Conotoxins have high diversity, with a detailed classification of more than 28 different gene superfamilies (namely A, B1, B2, B3, C, D, E, F, G, H, I1, I2, I3, J, K, L, M, N, O1, O2, O3, P, Q, R, S, T, V, Y) and 13 temporary gene superfamilies (Olivera et al, 1999;Kaas et al, 2010;Kaas et al, 2012;Puillandre et al, 2012;Ye et al, 2012;Aguilar et al, 2013;Dutertre et al, 2013;Luo et al, 2013;Li et al, 2020;Zamora-Bustillos et al, 2021). A total of 31 types of cysteine frameworks (I-V, VI/VII, VIII-XXX, XXXII, and XXXIII) and 12 pharmacological families (a, g, d, ϵ, i, k, µ, r, s, t, c, and wfamilies) have been defined by their molecular targets and pharmacological activities, respectively (Kaas et al, 2010;Kaas et al, 2012;Bernaldez et al, 2013).…”